# Amiodarone

## Amiodarone (Cordarone) inj 150mg/3mL

| TAH Drug Code      | [IAMIO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAMIO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Wolff-Parkinson-White syndrome, supraventricular & ventricular tachycardia, atrial & ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Must be administered using a volumetric infusion pump preferably via a central venous catheter. Initially 5 mg/kg in 250 mL of dextrose 5% IV infusion for 20 minutes to 2 hours. May repeat 2-3 times in 24 hours. Maintenance dose: 10-20 mg/kg (usually 600-800 mg/24 hours, maximum: 1.2 gm/24 hours) in 250 mL dextrose IV infusion. Cardiopulmonary resuscitation, Ventricular fibrillation/pulseless ventricular tachycardia: 300 mg IV by rapid infusion; a single dose of 150 mg IV may be repeated if Ventricular fibrillation/pulseless ventricular tachycardia recurs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | AV or SA block, sinus bradycardia, sick sinus syndrome except when used in conjunction with a pacemaker; history of thyroid dysfunction; iodine intolerance, severe arterial hypotension, CV collapse, acute cardiac insufficiency. Combined therapy with drugs which may induce torsades de pointes. Pregnancy, lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Common: Hypotension (Oral, less than 1%; IV, 15.6%), Photodermatitis (2-24%), Photosensitivity (3-10%), Thyroid dysfunction, Constipation (4-9%), Loss of appetite (4-9%), Nausea (10-33%), Vomiting (10-33%), Increased liver enzymes, Abnormal gait (4-9%), Coordination problem (4-9%), Dizziness (4-9%), Involuntary movement (4-9%), Movement disorder (4-9%), Paresthesia (4-9%), Peripheral neuropathy, Corneal deposit, Microdeposits, Visual disturbance (4-9%), Malaise and fatigue (4-9%) Serious: Bradyarrhythmia, Cardiac dysrhythmia, Congestive heart failure, High threshold for implanted defibrillator, Prolonged QT interval, Sinus arrest, Torsades de pointes (Less than 2%), Vasculitis, Ventricular arrhythmia, Injection site extravasation, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hyperthyroidism (2%), Hypothyroidism (Up to 10% .), Thyroid cancer, Thyrotoxicosis, Thrombocytopenia, Hepatotoxicity, Anaphylaxis, Hypersensitivity reaction, Lupus erythematosus, Low back pain, acute, Rhabdomyolysis, Pseudotumor cerebri, Raised intracranial pressure, Blindness AND/OR vision impairment level, Optic neuritis, Toxic optic neuropathy, Renal impairment, Acute respiratory distress syndrome (2%), Pulmonary fibrosis, Pulmonary toxicity (Up to 17%) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amiodarone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## Cordarone 200mg

| TAH Drug Code      | [OAMIO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OAMIO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Wolff-Parkinson-White syndrome, supraventricular & ventricular tachycardia, atrial & ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Initial dose: 600mg/day in divided doses for 8-10 days. Maintenance dose: dosage range from 100mg daily (200 mg every other day) to 400 mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | AV or SA block, sinus bradycardia, sick sinus syndrome except when used in conjunction with a pacemaker; history of thyroid dysfunction; iodine intolerance, severe arterial hypotension, CV collapse, acute cardiac insufficiency. Combined therapy with drugs which may induce torsades de pointes. Pregnancy, lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Common: Hypotension (Oral, less than 1%; IV, 15.6%), Photodermatitis (2-24%), Photosensitivity (3-10%), Thyroid dysfunction, Constipation (4-9%), Loss of appetite (4-9%), Nausea (10-33%), Vomiting (10-33%), Increased liver enzymes, Abnormal gait (4-9%), Coordination problem (4-9%), Dizziness (4-9%), Involuntary movement (4-9%), Movement disorder (4-9%), Paresthesia (4-9%), Peripheral neuropathy, Corneal deposit, Microdeposits, Visual disturbance (4-9%), Malaise and fatigue (4-9%) Serious: Bradyarrhythmia, Cardiac dysrhythmia, Congestive heart failure, High threshold for implanted defibrillator, Prolonged QT interval, Sinus arrest, Torsades de pointes (Less than 2%), Vasculitis, Ventricular arrhythmia, Injection site extravasation, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hyperthyroidism (2%), Hypothyroidism (Up to 10% .), Thyroid cancer, Thyrotoxicosis, Thrombocytopenia, Hepatotoxicity, Anaphylaxis, Hypersensitivity reaction, Lupus erythematosus, Low back pain, acute, Rhabdomyolysis, Pseudotumor cerebri, Raised intracranial pressure, Blindness AND/OR vision impairment level, Optic neuritis, Toxic optic neuropathy, Renal impairment, Acute respiratory distress syndrome (2%), Pulmonary fibrosis, Pulmonary toxicity (Up to 17%) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amiodarone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

